| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.25 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |